Follow The Filings

ZTS Zoetis

Zoetis earnings company data as of 7:06 PM ET 10/30

  • 0 of 1 EPS beats

History

2 periods, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 5 Nov EPS 1.52 — —
Rev $2.30B — —
FY2026 Q2 6 Aug EPS 1.84 1.63 Miss -11.4%
Rev — — —

Insider trades

Open-market buys and sales by ZTS's executives, directors and 10% owners in the last 12 months, from their Form 4s

All ZTS insider trades
  • $886K bought by 3 insiders
  • None no sales outside a trading plan
  • $2.5M sold by 1 insider under 10b5-1 plans
  1. Frank A Damelio Director
    Buy
    $501K 6,650 shares at $75.39 +45% to stake
    Traded May 13 Filed May 13
    ↗
  2. Paul Bisaro Director
    Buy
    $152K 2,000 shares at $75.88 +7.7% to stake
    Traded May 13 Filed May 13
    ↗
  3. Michael B McCallister Director
    Buy
    $233K 3,000 shares at $77.76 +14% to stake
    Traded May 11 Filed May 12
    ↗
  4. Kristin C Peck CEO
    Planned sale
    $2.5M 20,000 shares at $127.05 17% of stake
    Traded Feb 17 Filed Feb 17
    ↗

Also filed in the last 12 months, not counted as buying or selling: 42 option exercises, 30 share withholdings for taxes, 6 other transactions, and 3 gifts.

SEC filings

Recent issuer filings from EDGAR, 11 shown.

Filed Form Detail Links
8-K 5.02,7.01,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 5.02,9.01 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 5.02,5.07 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13G — Filing Doc

Source: SEC EDGAR submissions, updated 12 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.